Daiwa Securities Group’s LENZ Therapeutics LENZ Stock Holding History

Daiwa Securities Group’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-91	Closed	-$1K	–	1463
2025 Q4	$1K	Hold	91	–	–	﹤0.01%	1358
2025 Q3	$4K	Hold	91	–	–	﹤0.01%	1232
2025 Q2	$3K	Hold	91	–	–	﹤0.01%	1201
2025 Q1	$2K	Hold	91	–	–	﹤0.01%	1206
2024 Q4	$3K	Buy	+91	New	+$2.77K	﹤0.01%	1207
2023 Q4	–	Sell	-24	Closed	–	–	1402
2023 Q3	$0	Hold	24	–	–	﹤0.01%	1342
2023 Q2	$0	Hold	24	–	–	﹤0.01%	1354
2023 Q1	$0	Hold	24	–	–	﹤0.01%	1326
2022 Q4	$1K	Hold	24	–	–	﹤0.01%	1296
2022 Q3	$1K	Hold	24	–	–	﹤0.01%	1318
2022 Q2	$0	Hold	24	–	–	﹤0.01%	1439
2022 Q1	$1K	Hold	24	–	–	﹤0.01%	1349
2021 Q4	$2K	Buy	+24	New	+$1.99K	﹤0.01%	1305

Other funds holding LENZ

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AWG

Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

7IH

72 Investment Holdings Stamford, Connecticut $50M AUM 647.58% 1-Year Est. Return

Daiwa Securities Group's LENZ Position: Q1 2026 in Review

Daiwa Securities Group sold out of LENZ Therapeutics (LENZ) in Q1 2026, closing a stake of 91 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in LENZ in Q4 2021 and held it in 13 quarters. The position peaked at $4K in Q3 2025. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

Daiwa Securities Group reported no remaining LENZ Therapeutics position as of Q1 2026 after selling out during the quarter.
Daiwa Securities Group sold 91 LENZ Therapeutics shares in Q1 2026, an estimated $1K.
Daiwa Securities Group first reported a position in LENZ Therapeutics in Q4 2021 and held it in 13 quarters.
Daiwa Securities Group's LENZ Therapeutics position peaked at $4K in Q3 2025.
145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.